Verastem (VSTM) EBITDA (2011 - 2026)

Verastem's EBITDA history runs 16 years deep, the most recent figure standing at -$33.2 million for Q1 2026.

• In Q1 2026, EBITDA rose 26.97% year-over-year to -$33.2 million; the TTM figure through Mar 2026 stood at -$178.7 million (down 25.64% YoY), while the FY2025 annual figure was -$204.2 million, down 56.33% from the prior year.
• EBITDA was -$33.2 million for Q1 2026 at Verastem, down from -$25.1 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of -$8.3 million in Q2 2024 to a low of -$95.8 million in Q3 2025.
• Historically, EBITDA has averaged -$30.4 million across 5 years, with a median of -$24.3 million in 2023.
• The sharpest annual moves came in 2024 and 2025: EBITDA soared 66.02% in 2024, then sank 299.6% in 2025.
• A 5-year view of EBITDA shows it stood at -$16.8 million in 2022, then slumped by 63.42% to -$27.4 million in 2023, then slumped by 135.55% to -$64.6 million in 2024, then surged by 61.05% to -$25.1 million in 2025, then slumped by 32.06% to -$33.2 million in 2026.
• The last three EBITDA figures came in at -$33.2 million (Q1 2026), -$25.1 million (Q4 2025), and -$95.8 million (Q3 2025), per Business Quant data.